Lantheus Q4 Earnings Call Highlights [Yahoo! Finance]
Lantheus Holdings, Inc. (LNTH)
Last lantheus holdings, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.lantheus.com/investor-relations
Company Research
Source: Yahoo! Finance
legacy SPECT business to reallocate capital and expand its Alzheimer's and neuroendocrine diagnostic offerings. Management expects multiple FDA decisions in 2026 (including a new PSMA PET with PDUFA Mar. 6 and OCTEVY Mar. 29) but cautions these approvals will likely have limited near-term revenue impact due to launch sequencing, coding and reimbursement work; a regional transition to the new PSMA formulation is planned for Q4 2026 with material commercial impact in 2027. Q4 revenue was $406.8 million and FY2025 revenue $1.546 billion ; management guided 2026 net revenue of $1.4–1.45 billion and EPS of $5.00–5.25 , forecasting PYLARIFY down ~ 8–10% while expecting Neuraceq to grow triple digits after contributing $31 million in Q4. Interested in Lantheus Holdings, Inc.? Here are five stocks we like better. Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore Lantheus (NASDAQ:LNTH) executives on the company's fourth-quarter and full-year 2025 earnings call outlined a s
Show less
Read more
Impact Snapshot
Event Time:
LNTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNTH alerts
High impacting Lantheus Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LNTH
News
- Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTHBusiness Wire
- Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® [Yahoo! Finance]Yahoo! Finance
- Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®GlobeNewswire
- Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook [Yahoo! Finance]Yahoo! Finance
- Lantheus (LNTH) was given a new $89.00 price target by Truist Financial Corporation.MarketBeat
LNTH
Earnings
- 2/26/26 - Beat
LNTH
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- LNTH's page on the SEC website